Participants had a poor understanding of most of the evidence-based concepts in type 2 diabetes that were explored. This disadvantages them in being able to make informed decisions about their health care and actively manage their diabetes (International Journal of General Medicine)
Glycosmedia is dedicated to bringing free, non-promotional, editorially independent news to a global audience about developments in diabetes, and is primarily aimed at health professionals.
Intensive glycemic control and lipid interventions did not improve clinical outcomes in patients with type 2 diabetes (American Journal of Kidney Diseases)
Facebook , Twitter, the last few years have shown the ease of communication using technology where all aspects of someone can be followed on line and where a person’s once confidential information now seems to be open to the world. Compare that to communication between health care professionals involved in a patients care.
The adolescent and young adult years are difficult enough for a young person to handle, the additional burden of managing diabetes making this even harder.
Contrary to expectations, the linear advancement method was correlated to initial wound size in the longer duration wounds suggesting that in these chronic wounds, differing healing phases render the surface area calculation method superior to the linear advancement parameter (Wound Repair and Regeneration)
For children diagnosed with Type 1 diabetes aged under 6 years, good metabolic control was achievable until age 10 years, after which it deteriorated. Higher HbA1c levels observed in children diagnosed before the age of 6 years were associated with longer duration of disease (Diabetic Medicine)
This review provides an overview of the development of incretin-based therapies and explains their differing modes of action compared with traditional interventions (Clinical Endocrinology)
The absolute IENFD values from distal leg were significantly lower in both eDM2 (p
SMBG is beneficial for glycemic control and palm blood sampling is a useful procedure for OHA-treated T2D (Diabetes/Metabolism Research and Reviews)
As an outspoken critic of the coalition government’s health reforms, Baroness Barbara Young doesn’t hold back when asked about the future of the NHS. ‘I am concerned about integration,’ she says (GP)
This study provides clear evidence of altered axonal function in type 1 diabetic patients in the absence of clinical neuropathy. These findings suggest that altered axonal membrane potential may precede neuropathy onset in type 1 diabetes, and as such may indicate a window of opportunity to intervene and potentially reverse axonal membrane dysfunction before the development of irreversible neuropathy (Diabetes/Metabolism Research and Reviews)
The Alliance continues to reinforce its commitment to diabetes with data presentations on three molecules in three product classes, across type 1 and type 2 diabetes (Lilly)
This study demonstrates a new concept for accurate but cheap GDM screening. This approach should be further evaluated in different populations to ensure an optimised diagnostic algorithm (Diabetologia)
This review provides a comprehensive and sound summary of the current state of research on the prevalence of GDM in advances economies as a first step in identifying starting points for future interventions (Journal of Perinatal Medicine)
The in vitro effects of CRT on these functions are consistent with CRT’s potent effects on wound healing in the diabetic mouse. These studies implicate CRT as a potential powerful topical therapeutic agent for the treatment of diabetic and other chronic wounds (Wound Repair and Regeneration)
The linchpin is a biosensor engineered by Fraunhofer researchers: A tiny chip combines measurement and digital analysis – and can be radioed to a mobile device (Fraunhofer)
Taken together, these results suggest that autoantibody portraits derived from islet and organ-specific targets will likely be useful for enhancing the clinical management of T1D (PLoS ONE)
Novartis announced today that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued two positive opinions for new indications for the use of Galvus® (vildagliptin) and Eucreas® (vildagliptin and metformin) in combination with other treatments for type 2 diabetes patients (Novartis)
Children with type 1 diabetes had significantly different WM structure (as measured by A Diffusion Tenso) when compared with controls. In addition, WM structural differences (as measured by RD) were significantly correlated with their HbA1c values (Diabetes Care)
Researchers at the University of Copenhagen and Novo Nordisk A/S have now shown that the increased activity of one particular iron-transport protein destroys insulin-producing beta cells (University of Copenhagen)